DE69033511T2 - Verfahren zum Nachweis von Knochen- und anderen Bindegewebeerkrankungen in Menschen und Tieren - Google Patents

Verfahren zum Nachweis von Knochen- und anderen Bindegewebeerkrankungen in Menschen und Tieren

Info

Publication number
DE69033511T2
DE69033511T2 DE69033511T DE69033511T DE69033511T2 DE 69033511 T2 DE69033511 T2 DE 69033511T2 DE 69033511 T DE69033511 T DE 69033511T DE 69033511 T DE69033511 T DE 69033511T DE 69033511 T2 DE69033511 T2 DE 69033511T2
Authority
DE
Germany
Prior art keywords
bone
methods
connective tissue
biological fluids
humans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69033511T
Other languages
English (en)
Other versions
DE69033511D1 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rowett Research Institute
Original Assignee
Rowett Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rowett Research Institute filed Critical Rowett Research Institute
Application granted granted Critical
Publication of DE69033511D1 publication Critical patent/DE69033511D1/de
Publication of DE69033511T2 publication Critical patent/DE69033511T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/108—Osteoporosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Window Of Vehicle (AREA)
  • Slide Fasteners, Snap Fasteners, And Hook Fasteners (AREA)
  • Mechanical Coupling Of Light Guides (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
DE69033511T 1989-12-30 1990-12-28 Verfahren zum Nachweis von Knochen- und anderen Bindegewebeerkrankungen in Menschen und Tieren Expired - Lifetime DE69033511T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898929366A GB8929366D0 (en) 1989-12-30 1989-12-30 Method to detect connective tissue disorder in humans and animals

Publications (2)

Publication Number Publication Date
DE69033511D1 DE69033511D1 (de) 2000-05-25
DE69033511T2 true DE69033511T2 (de) 2000-11-16

Family

ID=10668604

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69033511T Expired - Lifetime DE69033511T2 (de) 1989-12-30 1990-12-28 Verfahren zum Nachweis von Knochen- und anderen Bindegewebeerkrankungen in Menschen und Tieren
DE69019375T Expired - Fee Related DE69019375T2 (de) 1989-12-30 1990-12-28 Verfahren zur detektion von knochen- und anderen bindegewebeerkrankungen bei menschen und tieren.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69019375T Expired - Fee Related DE69019375T2 (de) 1989-12-30 1990-12-28 Verfahren zur detektion von knochen- und anderen bindegewebeerkrankungen bei menschen und tieren.

Country Status (17)

Country Link
US (2) US5700693A (de)
EP (2) EP0507831B1 (de)
JP (3) JPH087212B2 (de)
KR (1) KR0138503B1 (de)
AT (2) ATE191976T1 (de)
AU (2) AU648774B2 (de)
BR (1) BR9007969A (de)
CA (2) CA2271544C (de)
DE (2) DE69033511T2 (de)
DK (1) DK0507831T3 (de)
ES (2) ES2147761T3 (de)
FI (1) FI923028A (de)
GB (1) GB8929366D0 (de)
GR (1) GR3016998T3 (de)
HU (1) HUT64421A (de)
NO (1) NO304760B1 (de)
WO (1) WO1991010141A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6121002A (en) * 1990-12-26 2000-09-19 The Rowett Research Institute Method to detect bone and other connective tissue disorders in humans and animals
GB9202139D0 (en) * 1992-01-31 1992-03-18 Sandoz Ltd Improvements in or relating to organic compounds
DE69321503T2 (de) * 1992-03-19 1999-05-06 Hoechst Marion Roussel Ltd Gewebeantigen und seine Anwendung in einem Nachweisverfahren von humaner Osteoporose
US5620861A (en) * 1992-07-31 1997-04-15 Metra Biosystems, Inc. Method and kit for pyridinium crosslink assay
US5527715A (en) * 1992-07-31 1996-06-18 Metra Biosystems, Inc. Method and kit for pyridinoline assay
WO1994006015A1 (en) * 1992-08-28 1994-03-17 The Rowett Research Institute Method to monitor drug therapy and assess metastasis
US5756361A (en) * 1992-12-17 1998-05-26 Metra Biosystems, Inc. Screening method for periodontal disease
US5736344A (en) * 1992-12-17 1998-04-07 Metra Biosystems, Inc. Serum pyridinium crosslinks assay
JPH0792165A (ja) * 1993-09-21 1995-04-07 Hoechst Japan Ltd 骨粗鬆症診断剤
US5661039A (en) * 1995-03-01 1997-08-26 Metra Biosystems, Inc. Perspiration assay for bone resorption
ES2214722T3 (es) * 1997-07-31 2004-09-16 Metra Biosystems, Inc. Metodo de ensayo de peptidos de colageno.
US6033918A (en) * 1997-11-10 2000-03-07 Bayer Corporation Method and device for the detection of analyte in a fluid sample
WO1999050666A1 (en) * 1998-03-27 1999-10-07 Bio-Rad Laboratories Gmbh Determination of the probability of bone metastases in patients with primary carcinomas
US6197592B1 (en) * 1999-07-15 2001-03-06 Bio-Rad Laboratories, Inc. Clinical control materials for detection of bone resorptive markers
EP1325339A2 (de) * 2000-10-03 2003-07-09 The Rowett Research Institute Verfahren zur bestimmung von pyrrol-enthaltenden biologischen substanzen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973666A (en) * 1987-11-06 1990-11-27 Washington Research Foundation Peptide fragments containing HP and LP cross-links
US5300434A (en) * 1987-11-06 1994-04-05 Washington Research Foundation Hybridoma cell line producing an antibody to type-I collagen amino-terminal telopeptide
US5283197A (en) * 1988-06-25 1994-02-01 The Rowett Research Institute Method of monitoring collagen degradation
GB8815174D0 (en) * 1988-06-25 1988-08-03 Rowett Research Inst Method of monitoring collagen degradation
GB8927377D0 (en) * 1989-12-04 1990-01-31 Univ Edinburgh Improvements in and relating to amperometric assays
US5620861A (en) * 1992-07-31 1997-04-15 Metra Biosystems, Inc. Method and kit for pyridinium crosslink assay
FI106326B (fi) * 1996-09-23 2001-01-15 Tellabs Oy Kytkentä kaiunpoistavan moninopeusmodeemin sovittamiseksi linjalle sekä kytkentämenetelmä

Also Published As

Publication number Publication date
HUT64421A (en) 1993-12-28
FI923028A0 (fi) 1992-06-30
JP3224356B2 (ja) 2001-10-29
EP0507831A1 (de) 1992-10-14
JPH05502942A (ja) 1993-05-20
FI923028A (fi) 1992-06-30
CA2069611C (en) 1999-08-10
AU7065991A (en) 1991-07-24
DE69019375T2 (de) 1995-09-14
ATE122467T1 (de) 1995-05-15
US5700694A (en) 1997-12-23
KR0138503B1 (en) 1998-05-15
CA2069611A1 (en) 1991-07-01
DE69033511D1 (de) 2000-05-25
NO922573L (no) 1992-06-29
NO922573D0 (no) 1992-06-29
AU648774B2 (en) 1994-05-05
ES2071979T3 (es) 1995-07-01
GR3016998T3 (en) 1995-11-30
ES2147761T3 (es) 2000-10-01
AU682188B2 (en) 1997-09-25
CA2271544A1 (en) 1991-07-01
EP0507831B1 (de) 1995-05-10
CA2271544C (en) 2006-01-17
GB8929366D0 (en) 1990-02-28
EP0618448B1 (de) 2000-04-19
JP2001050958A (ja) 2001-02-23
HU9202178D0 (en) 1992-10-28
JPH1045800A (ja) 1998-02-17
NO304760B1 (no) 1999-02-08
WO1991010141A1 (en) 1991-07-11
ATE191976T1 (de) 2000-05-15
DK0507831T3 (da) 1995-10-09
EP0618448A1 (de) 1994-10-05
AU6864894A (en) 1994-11-24
US5700693A (en) 1997-12-23
DE69019375D1 (de) 1995-06-14
BR9007969A (pt) 1993-02-02
JPH087212B2 (ja) 1996-01-29

Similar Documents

Publication Publication Date Title
DE69033511D1 (de) Verfahren zum Nachweis von Knochen- und anderen Bindegewebeerkrankungen in Menschen und Tieren
DE69029257T2 (de) Anordnung zur bestrahlung von laserstrahlen
WO2003087767A3 (en) A system and method for quantifying the dynamic response of a target system
IL85599A (en) Method,apparatus and kits for determining the interaction of tissue and various agents
ES2157326T3 (es) Sistema para el tratamiento de anomalias en la cascada de coagulacion sanguinea.
DE68918103D1 (de) Verfahren zur überwachung des kollagenabbaus.
ATE455554T1 (de) Verfahren zur erhöhung der mageren fleischmasse mit fettleibigkeitsprotein (ob) zusammensetzungen
DE69226548D1 (de) Verfahren zum Nachweis des Abbaus von Typ-I-Kollagen
DE69821246D1 (de) Testverfahren für collagenpeptid
ATE347697T1 (de) Methode zur bestimmung von proteinfragmenten in körperflüssigkeiten
DK0764273T3 (da) Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose
ATE352039T1 (de) Verfahren zur bestimmung der aktivität von thymidinkinase-1 und dessen verwendung
EA199800352A1 (ru) ПОЛИПЕПТИД ХЕМОКИНА β-8 (ВАРИАНТЫ) И СПОСОБ ЕГО ПОЛУЧЕНИЯ, КОМПОЗИЦИИ ПОЛИПЕПТИДОВ, ВЕКТОР, КЛЕТКА-ХОЗЯИН, АГОНИСТ И АНТАГОНИСТ, ВСЕ - УПОМЯНУТОГО ПОЛИПЕПТИДА, И СПОСОБ ИДЕНТИФИКАЦИИ ПОСЛЕДНЕГО, СПОСОБ ЛЕЧЕНИЯ БОЛЬНОГО, ИСПЫТЫВАЮЩЕГО ПОТРЕБНОСТЬ В Хк-β-8 (ВАРИАНТЫ), СПОСОБ ЛЕЧЕНИЯ БОЛЬНОГО, ИСПЫТЫВАЮЩЕГО ПОТРЕБНОСТЬ В ПОДАВЛЕНИИ Хк-β-8, СПОСОБ ДИАГНОСТИКИ ЗАБОЛЕВАНИЯ ИЛИ ПРЕДРАСПОЛОЖЕННОСТИ К ЗАБОЛЕВАНИЮ, ОБУСЛОВЛЕННОМУ НЕДОСТАТОЧНОЙ ЭКСПРЕССИЕЙ ПОЛИПЕПТИДА
DE3850728D1 (de) Methode zur Bestimmung des Verhaltens von Medikamenten in Lebewesen.
ATE198770T1 (de) Monoklonale antikörper gegen das humane tnf- bindende protein i (tnf-bp i)
DE69734890D1 (de) Rdgb-proteine
ES2099876T3 (es) Procedimiento para la determinacion de anticuerpos de lupus anticoagulante que provocan trombosis.
DE69010682D1 (de) Verfahren zum analysieren von füssen zur bestimmung geeigneten schuhwerks und dafür geeigneter fussanalyseapparat.
IT1242173B (it) Metodo di analisi quantitativa altamente sensibile di acidi biliari e composizione per la analisi quantitativa.
ATE115379T1 (de) Verfahren und vorrichtung zum nachweis von kataraktogenesen.

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: VONNEMANN, KLOIBER & KOLLEGEN, 80796 MUENCHEN